by Kastro
Paper/Archive/CVE-2022-45611

CVE-2022-45611

mitre — An issue was discovered in Fresenius Kabi PharmaHelp 5.1.759.0 allows attackers to gain escalated privileges via via capture of user logi…

EPSS 1%CVSS 9.8
critical.is priorityof 100
43
CVSS 9.8 (NVD)9.8 / 10 × 3029.4Not in CISA KEV+300.0EPSS percentile 67.6.676 × 2013.5No public exploit+100.0SSVC exploitation: none+100.0
Description · from the CVE record

An issue was discovered in Fresenius Kabi PharmaHelp 5.1.759.0 allows attackers to gain escalated privileges via via capture of user login information.

Affected

ProductAffectedFixed inSource
n/an/a–CNA

Scores by source

NVD9.8CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:H/I:H/A:H
CISA ADPSSVCExploitation: none · Automatable: yes · Technical impact: total

References

reffresenius-kabi.com/de-at/produkte/pharmahelp-compounderreffresenius.com/sites/default/files/2023-11/Fresenius%20-%20CVE-2022-45611.pdfreffresenius.com/sites/default/files/2023-12/Fresenius%20-%20CVE-2022-45611.pdf